Dexcom Inc
DXCM- Exchange
- Nasdaq
- Industry
- Surgical & Medical Instruments & Apparatus
- SEC CIK
- 0001093557
In the last 90 days, Dexcom Inc insiders filed 0 open-market purchases and 11 sales; 975 institutions reported holding it in 13F filings for Q2 2026, worth $26.0B in total; no superinvestor holds it.
Superinvestors holding DXCM, Q2 2026
No superinvestor reported holding DXCM in Q2 2026.
Moves by quarter
Superinvestors that opened, added to, trimmed or sold out of DXCM each quarter, comparing shares with the quarter before. A superinvestor that didn't file for a quarter isn't listed, and isn't counted as selling.
Q3 2024
0 superinvestors holding at quarter end
Q2 2024
3 superinvestors holding at quarter end
- New
- Maverick Capital
- Added
- Soros Fund Management (+233.6%)
Q1 2024
2 superinvestors holding at quarter end
- Reduced
- Soros Fund Management (−54.5%)
- Sold out
- Maverick Capital
Q4 2023
3 superinvestors holding at quarter end
- New
- Tiger Global Management
- Reduced
- Soros Fund Management (−40.5%), Maverick Capital (−58.5%)
Q3 2023
2 superinvestors holding at quarter end
Q3 2022
0 superinvestors holding at quarter end
- Sold out
- Coatue Management
Q1 2022
1 superinvestor holding at quarter end
- Reduced
- Coatue Management (−67.8%)
Q4 2021
1 superinvestor holding at quarter end
- Reduced
- Coatue Management (−41.3%)
- Sold out
- Lone Pine Capital
Q3 2021
2 superinvestors holding at quarter end
- Reduced
- Lone Pine Capital (−22.9%), Coatue Management (−0.8%)
- Sold out
- Maverick Capital
Q2 2021
3 superinvestors holding at quarter end
- Added
- Coatue Management (+433.6%)
- Reduced
- Lone Pine Capital (−21.3%), Maverick Capital (−92.8%)